Amgen : AMGN

All Amgen Articles

704 Articles

Lee Jackson | Oct 3, 2013 at 11:50 AM EDT

Top Biotechs Set to Win in the War on Cancer

ThinkstockTuesday saw the wrap up of the 2013 European Society of Medical Oncology (ESMO) conference in Amsterdam, which featured key…

Lee Jackson | Sep 4, 2013 at 8:25 AM EDT

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

ThinkstockEven though the equity strategy team at UBS has downgraded U.S. equities to Neutral from Outperform, they remain very positive…

Jon C. Ogg | Aug 26, 2013 at 1:29 PM EDT

Will Attorney Investigations or Class Action Suits Put Amgen-Onyx Buyout at Risk?

Any time you see a merger announcement, you see a myriad of press releases pertaining to law firms and lawyers…

Jon C. Ogg | Aug 26, 2013 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: 3D, Hasbro, Dollar Tree, Tyson and More

Jon OggThis will be an interesting week for Wall Street analyst coverage as many traders, investors and analysts are out…

Jon C. Ogg | Aug 26, 2013 at 8:05 AM EDT

Lessons of Buying Growth Companies Doubling Their Revenues

ThinkstockAmgen Inc. (NASDAQ: AMGN) wants to regain its status as the largest publicly traded biotech in the U.S. The company formalized…

Jon C. Ogg | Aug 1, 2013 at 8:25 AM EDT

Deutsche Bank Raises Price Targets on Some of Its Top Stocks to Buy

ThinkstockWith the Federal Reserve reminding investors yesterday that it can raise or lower asset purchases in its quantitative easing program…

Paul Ausick | Jul 31, 2013 at 4:25 PM EDT

Closing Bell for Wednesday on Wall Street: Markets Open Higher, Dive to Mixed Close

July 31, 2013: U.S. equity markets opened higher this morning as traders and investors this afternoon’s announcement from the FOMC.…

Paul Ausick | Jul 30, 2013 at 4:07 PM EDT

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Drift to Mixed Close

July 30, 2013: U.S. equity markets opened higher this morning as traders and investors wait for tomorrow’s announcement from the…

Jon C. Ogg | Jul 23, 2013 at 8:25 AM EDT

UBS Top Stocks to Buy That Can Beat Earnings Estimates

courtesy of FordThe equity analysts and strategists at UBS A.G. (NYSE: UBS) expect to see U.S. equities continue to conform…

Jon C. Ogg | Jul 2, 2013 at 8:45 AM EDT

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

ThinkstockOn Friday after the market closed, biotech giant Amgen Inc. (NASDAQ: AMGN) made an unsolicited $120 per share bid for…

Paul Ausick | Jul 2, 2013 at 7:35 AM EDT

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

ThinkstockAlthough Amgen Inc.’s (NASDAQ: AMGN) $10 billion offer for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) was unsolicited and not exactly a…

Paul Ausick | Jul 1, 2013 at 4:03 PM EDT

Closing Bell for Monday on Wall Street: Markets Open Higher, Hold Gains

July 1, 2013: U.S. equity markets opened higher this morning after a blast of economic data from both Asia and…

Paul Ausick | Jul 1, 2013 at 7:35 AM EDT

Onyx Pharma Rejects Amgen, but Will Start Search for a Buyer

ThinkstockCancer-drug developer Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) issued a terse press release yesterday, saying it had “received and rejected” a…

Jon C. Ogg | May 15, 2013 at 8:10 AM EDT

Deutsche Bank Firm on Biotech Stocks to Buy

ThinkstockBiotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and…

Paul Ausick | May 8, 2013 at 4:05 PM EDT

Closing Bell for Wednesday on Wall Street: Markets Open Lower, Stock Prices Rise All Day

U.S. equity markets opened lower this morning on relatively little economic data. In Europe, Germany reported that industrial production rose…

1 … 31 32 33 34 35 … 47

Amgen : AMGN

All Amgen Articles

Top Biotechs Set to Win in the War on Cancer

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

Will Attorney Investigations or Class Action Suits Put Amgen-Onyx Buyout at Risk?

Top Analyst Upgrades and Downgrades: 3D, Hasbro, Dollar Tree, Tyson and More

Lessons of Buying Growth Companies Doubling Their Revenues

Deutsche Bank Raises Price Targets on Some of Its Top Stocks to Buy

Closing Bell for Wednesday on Wall Street: Markets Open Higher, Dive to Mixed Close

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Drift to Mixed Close

UBS Top Stocks to Buy That Can Beat Earnings Estimates

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

Closing Bell for Monday on Wall Street: Markets Open Higher, Hold Gains

Onyx Pharma Rejects Amgen, but Will Start Search for a Buyer

Deutsche Bank Firm on Biotech Stocks to Buy

Closing Bell for Wednesday on Wall Street: Markets Open Lower, Stock Prices Rise All Day

The Hardest Retirement Money Decisions Pile Up Just as the Mind Slows. A 68-Year-Old Is Locking In Her Social Security and Tax Moves While She’s Sharp.

After Laying Off 3,200 Employees, Xbox CEO Joins the Fed’s Jobs Task Force

Sell a Rental Property Once, and Medicare Treats You as Wealthy for 24 Months

The Hardest Retirement Money Decisions Pile Up Just as the Mind Slows. A 68-Year-Old Is Locking In Her Social Security and Tax Moves While She's Sharp.

Sell a Rental Property Once, and Medicare Treats You as Wealthy for 24 Months

The Hardest Retirement Money Decisions Pile Up Just as the Mind Slows. A 68-Year-Old Is Locking In Her Social Security and Tax Moves While She’s Sharp.

After Laying Off 3,200 Employees, Xbox CEO Joins the Fed’s Jobs Task Force

Amgen : AMGN

All Amgen Articles

Top Biotechs Set to Win in the War on Cancer

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

Will Attorney Investigations or Class Action Suits Put Amgen-Onyx Buyout at Risk?

Top Analyst Upgrades and Downgrades: 3D, Hasbro, Dollar Tree, Tyson and More

Lessons of Buying Growth Companies Doubling Their Revenues

Deutsche Bank Raises Price Targets on Some of Its Top Stocks to Buy

Closing Bell for Wednesday on Wall Street: Markets Open Higher, Dive to Mixed Close

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Drift to Mixed Close

UBS Top Stocks to Buy That Can Beat Earnings Estimates

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

Closing Bell for Monday on Wall Street: Markets Open Higher, Hold Gains

Onyx Pharma Rejects Amgen, but Will Start Search for a Buyer

Deutsche Bank Firm on Biotech Stocks to Buy

Closing Bell for Wednesday on Wall Street: Markets Open Lower, Stock Prices Rise All Day

The Hardest Retirement Money Decisions Pile Up Just as the Mind Slows. A 68-Year-Old Is Locking In Her Social Security and Tax Moves While She’s Sharp.

After Laying Off 3,200 Employees, Xbox CEO Joins the Fed’s Jobs Task Force

Sell a Rental Property Once, and Medicare Treats You as Wealthy for 24 Months

Featured Reads

The Hardest Retirement Money Decisions Pile Up Just as the Mind Slows. A 68-Year-Old Is Locking In Her Social Security and Tax Moves While She's Sharp.

Sell a Rental Property Once, and Medicare Treats You as Wealthy for 24 Months